These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22425027)

  • 1. Impact of the UK colorectal cancer screening pilot studies on incidence, stage distribution and mortality trends.
    McClements PL; Madurasinghe V; Thomson CS; Fraser CG; Carey FA; Steele RJ; Lawrence G; Brewster DH
    Cancer Epidemiol; 2012 Aug; 36(4):e232-42. PubMed ID: 22425027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.
    Zorzi M; Fedeli U; Schievano E; Bovo E; Guzzinati S; Baracco S; Fedato C; Saugo M; Dei Tos AP
    Gut; 2015 May; 64(5):784-90. PubMed ID: 25179811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal occult blood testing in areas of high incidence and mortality; the effect of screening the population aged 50 to 59.
    Fisher R; Rooney PS
    Colorectal Dis; 2011 Sep; 13(9):1024-9. PubMed ID: 20626761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site.
    Steele RJ; McClements P; Watling C; Libby G; Weller D; Brewster DH; Black R; Carey FA; Fraser CG
    Gut; 2012 Apr; 61(4):576-81. PubMed ID: 21930729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.
    Mandel JS; Church TR; Ederer F; Bond JH
    J Natl Cancer Inst; 1999 Mar; 91(5):434-7. PubMed ID: 10070942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of bowel cancer screening on the management of colorectal cancer.
    Hwang MJ; Evans T; Lawrence G; Karandikar S
    Colorectal Dis; 2014 Jun; 16(6):450-8. PubMed ID: 24617851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of faecal occult blood test screening on emergency admissions and short-term outcomes for colorectal cancer.
    Libby G; Brewster DH; Steele RJ
    Br J Surg; 2014 Nov; 101(12):1607-15. PubMed ID: 25219923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of population-based faecal occult blood test screening upon emergency colorectal cancer admissions in Coventry and north Warwickshire.
    Goodyear SJ; Leung E; Menon A; Pedamallu S; Williams N; Wong LS
    Gut; 2008 Feb; 57(2):218-22. PubMed ID: 18048571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcome of patients with screening versus symptomatically detected colorectal cancers.
    Pande R; Froggatt P; Baragwanath P; Harmston C
    Colorectal Dis; 2013 Jan; 15(1):74-9. PubMed ID: 22672571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences.
    Massat NJ; Moss SM; Halloran SP; Duffy SW
    J Med Screen; 2013; 20(3):125-48. PubMed ID: 24197771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom.
    UK Colorectal Cancer Screening Pilot Group
    BMJ; 2004 Jul; 329(7458):133. PubMed ID: 15237087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The National Health Service Bowel Cancer Screening Program: the early years.
    Rees CJ; Bevan R
    Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5):421-37. PubMed ID: 23899282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with a two-tier reflex gFOBT/FIT strategy in a national bowel screening programme.
    Fraser CG; Digby J; McDonald PJ; Strachan JA; Carey FA; Steele RJ
    J Med Screen; 2012 Mar; 19(1):8-13. PubMed ID: 22156144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.
    Denis B; Ruetsch M; Strentz P; Vogel JY; Guth F; Boyaval JM; Pagnon X; Ebelin JF; Gendre I; Perrin P
    Gut; 2007 Nov; 56(11):1579-84. PubMed ID: 17616542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
    Hardcastle JD; Chamberlain JO; Robinson MH; Moss SM; Amar SS; Balfour TW; James PD; Mangham CM
    Lancet; 1996 Nov; 348(9040):1472-7. PubMed ID: 8942775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening for colorectal cancer in Italy, 2010 survey].
    Zorzi M; Fedato C; Grazzini G; Sassoli de' Bianchi P; Naldoni C; Pendenza M; Sassatelli R; Senore C; Visioli CB; Zappa M
    Epidemiol Prev; 2012; 36(6 Suppl 1):55-77. PubMed ID: 23293271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer.
    Steele RJ; McClements PL; Libby G; Black R; Morton C; Birrell J; Mowat NA; Wilson JA; Kenicer M; Carey FA; Fraser CG
    Gut; 2009 Apr; 58(4):530-5. PubMed ID: 19036949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local impact of the English arm of the UK Bowel Cancer Screening Pilot study.
    Goodyear SJ; Stallard N; Gaunt A; Parker R; Williams N; Wong L
    Br J Surg; 2008 Sep; 95(9):1172-9. PubMed ID: 18690636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of faecal occult blood screening on incidence and mortality from colorectal cancer.
    Hamza S; Cottet V; Touillon N; Dancourt V; Bonithon-Kopp C; Lepage C; Faivre J
    Dig Liver Dis; 2014 Dec; 46(12):1121-5. PubMed ID: 25241134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.